Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements

Jul 1, 2025 - 10:00
 0  0
Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements
Torrance CA, June 26, 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and Drug Administration (FDA) approval for changes to the labelling of Endari to reflect...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0